Year |
Citation |
Score |
2008 |
Sun L, Geng X, Geney R, Li Y, Simmerling C, Li Z, Lauher JW, Xia S, Horwitz SB, Veith JM, Pera P, Bernacki RJ, Ojima I. Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids. The Journal of Organic Chemistry. 73: 9584-93. PMID 18975909 DOI: 10.1021/Jo801713Q |
0.58 |
|
2005 |
Geney R, Chen J, Ojima I. Recent advances in the new generation taxane anticancer agents. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 1: 125-39. PMID 16787308 DOI: 10.2174/1573406053175292 |
0.547 |
|
2005 |
Geney R, Sun L, Pera P, Bernacki RJ, Xia S, Horwitz SB, Simmerling CL, Ojima I. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design. Chemistry & Biology. 12: 339-48. PMID 15797218 DOI: 10.1016/J.Chembiol.2005.01.004 |
0.549 |
|
2004 |
Geng X, Geney R, Pera P, Bernacki RJ, Ojima I. Design and synthesis of de novo cytotoxic alkaloids through mimicking taxoid skeleton. Bioorganic & Medicinal Chemistry Letters. 14: 3491-4. PMID 15177459 DOI: 10.1016/J.Bmcl.2004.04.060 |
0.553 |
|
2003 |
Ojima I, Geney R. 109881 Aventis. Current Opinion in Investigational Drugs (London, England : 2000). 4: 737-40. PMID 12901234 |
0.428 |
|
2003 |
Ojima I, Geney R. BMS-184476 Bristol-Myers Squibb. Current Opinion in Investigational Drugs (London, England : 2000). 4: 732-6. PMID 12901233 |
0.416 |
|
2002 |
Geney R, Ungureanu lM, Li D, Ojima I. Overcoming multidrug resistance in taxane chemotherapy. Clinical Chemistry and Laboratory Medicine. 40: 918-25. PMID 12435109 DOI: 10.1515/Cclm.2002.161 |
0.553 |
|
2002 |
Ojima I, Geney R, Ungureanu IM, Li D. Medicinal chemistry and chemical biology of new generation taxane antitumor agents. Iubmb Life. 53: 269-74. PMID 12121008 DOI: 10.1080/15216540212658 |
0.534 |
|
2002 |
Chuang CY, Vassar VC, Ma Z, Geney R, Ojima I. Electronic effects on the regio- and enantioselectivity of the asymmetric aminohydroxylation of O-substituted 4-hydroxy-2-butenoates. Chirality. 14: 151-62. PMID 11835558 DOI: 10.1002/Chir.10050 |
0.526 |
|
Show low-probability matches. |